相关实验视频

Updated: May 24, 2025

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

探索质瘤中外体源非编码RNA的作用和临床潜力

Peng Jin¹, Xue Bai²

¹Department of Neurosurgery, Hulunbuir People's Hospital, Hulunbuir, Inner Mongolia Autonomous Region 021000, China.

IBRO neuroscience reports

|March 4, 2025

概括

外体内非编码RNA对质瘤的发展和进展至关重要. 向这些外体非编码RNA为早期诊断和新的质瘤治疗提供了潜力.

科学领域:

基因组学就是基因组学.
分子生物学分子生物学
在瘤学瘤学.

背景情况:

非编码RNA构成98-99%的人类基因组,在真核生物中发挥着重要的调节作用,并参与癌症的发展.
外体,作为生物载体,富含非编码RNA,其中一些特别涉及质瘤等癌症.
质瘤是一种常见的原发性脑瘤,表现为高恶性瘤,快速增殖和血管化,往往导致预后不佳.

研究的目的:

审查质瘤中外体非编码RNA的起源,特征和功能作用.
探索外体非编码RNA作为结质瘤的诊断标记物和治疗点的潜在临床应用.
通过调节外生体生产和非编码RNA表达来提供关于质瘤预防和治疗的新策略的见解.

主要方法:

关于癌症,特别是质瘤中的外体非编码RNA的文献综述.
对外体非编码RNA在质瘤瘤发生路径中的参与进行分析.
检查目前和潜在的临床应用外体非编码RNAs在质瘤管理.

主要成果:

外体非编码RNA涉及多种质瘤过程,包括血管生成,增殖,入侵,免疫逃避,亡和自.
这些RNAs显示为早期质瘤诊断和预后预测的生物标志物具有前途.
调节外体细胞生产和外体非编码RNA水平为质瘤提供了潜在的治疗途径.

结论:

外体非编码RNA是质瘤生物学和进展的组成部分.
它们代表了开发质瘤创新诊断和治疗策略的有价值的目标.
对外体非编码RNA的进一步研究可能会彻底改变质瘤治疗方法.

关键词:

生物标志物生物标志物外基因组是外基因组的组成部分.质瘤是一种质瘤.这是一个RNARNARNARNARNA.信号传输传导的信号传输.

更多相关视频

Preparation of Exosomes for siRNA Delivery to Cancer Cells

Preparation of Exosomes for siRNA Delivery to Cancer Cells

Published on: December 5, 2018

Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool

Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool

Published on: May 27, 2016

相关概念视频

Overview of Exosomes

Overview of Exosomes

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...

lncRNA - Long Non-coding RNAs

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...

MicroRNAs

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...